Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen and the menopause

S S Yen

    American Family Physician
    |July 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Current estrogen therapy for menopausal symptoms involves large, non-physiologic hormone fluctuations. A more physiologic approach uses small daily doses of ethinyl estradiol or 17 beta-estradiol for three weeks, with a one-week break, and adding medroxyprogesterone in the third week.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Synchronous Pulsatile Release of Luteinizing Hormone and Immunoreactive Beta-Endorphin from the Human Pituitary in vitro.

    Journal of neuroendocrinology·2009
    Same author

    Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Supporting residents' EBM research on faculty's outpatient case studies.

    Academic medicine : journal of the Association of American Medical Colleges·2001
    Same author

    Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women.

    The journals of gerontology. Series A, Biological sciences and medical sciences·2000
    Same author

    The insulin-like growth factor system in the GT1-7 GnRH neuronal cell line.

    Neuroendocrinology·1999
    Same author

    Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.

    Human reproduction (Oxford, England)·1999
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Gynecology
    • Pharmacology

    Background:

    • Current estrogen therapy regimens for menopausal symptoms often result in non-physiologic hormone level fluctuations.
    • These large, daily peaks in circulating estrogen may lead to abnormal cellular stimulation and activity.

    Purpose of the Study:

    • To recommend a more physiologic and potentially safer estrogen dosage schedule for managing menopausal symptoms.
    • To suggest an alternative regimen that minimizes adverse effects associated with current popular treatments.

    Main Methods:

    • The study proposes a modified dosage schedule for estrogen therapy.
    • This involves administering small daily doses of ethinyl estradiol or 17 beta-estradiol for three weeks, followed by a one-week interruption.
    • Medroxyprogesterone is recommended in a small dose during the third week of estrogen treatment.

    Related Experiment Videos

    Main Results:

    • The proposed regimen aims to create more stable, physiologic estrogen levels.
    • This approach is expected to reduce the risks associated with large, fluctuating hormone peaks.
    • It may lead to more normal patterns of target cell stimulation.

    Conclusions:

    • The recommended dosage schedule offers a more physiologic alternative for estrogen therapy in menopausal women.
    • This regimen may help prevent abnormal cellular activity induced by current non-physiologic dosing.
    • It provides a potentially safer and more effective way to control menopausal symptoms.